Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City.

× No keyword cloud information.

16 in total

1. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors.

Authors: H Hagan; J P McGough; H Thiede; S Hopkins; J Duchin; E R Alexander
Journal: J Subst Abuse Treat Date: 2000-10

2. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors: H Hagan; H Thiede
Journal: J Urban Health Date: 2000-09 Impact factor: 3.671

3. Cost-effectiveness of screening patients for hepatitis C.

Authors: F D Gordon
Journal: Am J Med Date: 1999-12-27 Impact factor: 4.965

4. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.

Authors: S Kaur; L Rybicki; B R Bacon; J L Gollan; V K Rustgi; W D Carey
Journal: Hepatology Date: 1996-11 Impact factor: 17.425

Review 5. Hepatitis C: Part II. Prevention counseling and medical evaluation.

Authors: L A Moyer; E E Mast; M J Alter
Journal: Am Fam Physician Date: 1999-01-15 Impact factor: 3.292

6. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors: R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal: Am J Public Health Date: 1996-05 Impact factor: 9.308

7. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Authors: K Stark; R Müller; U Bienzle; I Guggenmoos-Holzmann
Journal: AIDS Date: 1996-03 Impact factor: 4.177

8. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors: H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal: Am J Public Health Date: 1995-11 Impact factor: 9.308

9. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors: H Thiede; H Hagan; C S Murrill
Journal: J Urban Health Date: 2000-09 Impact factor: 3.671

10. The importance of preventing hepatitis C virus infection among injection drug users in the United States.

Authors: M J Alter; L A Moyer
Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998

3 in total

Review 1. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors: Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal: Clin Infect Dis Date: 2005-04-15 Impact factor: 9.079

Review 2. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors: Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal: Cochrane Database Syst Rev Date: 2017-09-18

3. Hepatitis C virus infection in San Francisco's HIV-infected urban poor.

Authors: Christopher S Hall; Edwin D Charlebois; Judith A Hahn; Andrew R Moss; David R Bangsberg
Journal: J Gen Intern Med Date: 2004-04 Impact factor: 5.128

3 in total